Armata Pharmaceuticals, INC. (ARMP) SEC Filings — 2024
19 SEC filings for Armata Pharmaceuticals, INC. (ARMP) in 2024.
Filings
- Armata Pharmaceuticals Files 8-K — 8-K · Dec 19, 2024
- Armata Pharma Appoints New CMO, Elects Director — 8-K · Dec 4, 2024
- Armata Pharmaceuticals Announces Material Agreement and Officer Changes — 8-K · Nov 15, 2024
- Innoviva Amends Stake in Armata Pharmaceuticals — SC 13D/A · Nov 14, 2024
- Armata Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Armata Pharmaceuticals Files 8-K — 8-K · Nov 12, 2024
- Armata Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Oct 3, 2024
- Armata Pharmaceuticals Announces CMO Departure, Appoints Interim — 8-K · Sep 26, 2024
- Armata Pharmaceuticals Files 8-K — 8-K · Aug 26, 2024
- Armata Pharma Reports Officer/Director Changes & Compensation — 8-K · Aug 15, 2024
- Armata Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Armata Pharmaceuticals Appoints New CMO, Adds Directors — 8-K · Jul 25, 2024
- Armata Pharmaceuticals Reports Shareholder Vote — 8-K · Jun 14, 2024
- Armata Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Armata Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Shareholders — DEF 14A · Apr 29, 2024
- Armata Pharmaceuticals Files 8-K — 8-K · Mar 22, 2024
- Armata Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- Armata Pharmaceuticals Enters Material Agreement, Creates Financial Obligation — 8-K · Mar 4, 2024
- Innoviva Files 13D/A for Armata Pharmaceuticals — SC 13D/A · Mar 4, 2024